In the patient group referred to as “immune overdrive” patients, TEs activate the IFN-mediated inflammatory pathway in immune cells but not in tumor cells, triggering in immune cells the expression of PD-L1 and thus promoting immune evasion [93]. The gene discussed is IFNA1; the disease is neoplasm.